LIfT Biosciences – Summary
LIfT Biosciences’ aim is clear: to develop a cure for pancreatic cancer by 2021. As a socially-minded Biotech start-up, they have been developing the world’s first cell bank of cancer killing granulocytes (a type of white blood cell).